Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glypican-3 as a serum marker for hepatocellular carcinoma.

× No keyword cloud information.

15 in total

Review 1. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.

Authors: Yukihiro Haruyama; Hiroaki Kataoka
Journal: World J Gastroenterol Date: 2016-01-07 Impact factor: 5.742

2. High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening.

Authors: Yen Phung; Wei Gao; Yan-Gao Man; Satoshi Nagata; Mitchell Ho
Journal: MAbs Date: 2012-07-23 Impact factor: 5.857

Review 3. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma.

Authors: Jorge Filmus; Mariana Capurro
Journal: Mol Diagn Date: 2004

4. Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma.

Authors: Noriyuki Akutsu; Hiroyuki Yamamoto; Shigeru Sasaki; Hiroaki Taniguchi; Yoshiaki Arimura; Kohzoh Imai; Yasuhisa Shinomura
Journal: World J Gastroenterol Date: 2010-07-28 Impact factor: 5.742

5. Induction of latency-associated peptide (transforming growth factor-β(1)) expression on CD4+ T cells reduces Toll-like receptor 4 ligand-induced tumour necrosis factor-α production in a transforming growth factor-β-dependent manner.

Authors: Sandra Boswell; Shayan Sharif; Akeel Alisa; Stephen P Pereira; Roger Williams; Shahriar Behboudi
Journal: Immunology Date: 2011-03-23 Impact factor: 7.397

Glypican-3 as a serum marker for hepatocellular carcinoma.

Review 1. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.

2. High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening.

Review 3. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma.

4. Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma.

5. Induction of latency-associated peptide (transforming growth factor-β(1)) expression on CD4+ T cells reduces Toll-like receptor 4 ligand-induced tumour necrosis factor-α production in a transforming growth factor-β-dependent manner.

6. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.

Review 7. Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.

8. The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.

9. Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease.

Review 10. Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.